title: Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
authors.forename: Iris
authors.initials: I
authors.lastname: Kamphausen
authors.forename: Franziska
authors.initials: F
authors.lastname: Schulze
authors.forename: Enno
authors.initials: E
authors.lastname: Schmidt
authors.forename: Detlef
authors.initials: D
authors.lastname: Zillikens
authors.forename: Manfred
authors.initials: M
authors.lastname: Kunz
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000906:Antibodies / Q000097:blood; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D051184:Desmoglein 3 / Q000276:immunology; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007164:Immunosorbents / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000097:blood / Q000188:drug therapy*; D000069283:Rituximab; D012536:Scalp Dermatoses / Q000188:drug therapy*; D013205:Staphylococcal Protein A / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D000906:Antibodies; D058846:Antibodies, Monoclonal, Murine-Derived; C071894:DSG3 protein, human; D051184:Desmoglein 3; D007155:Immunologic Factors; D007164:Immunosorbents; D007166:Immunosuppressive Agents; D013205:Staphylococcal Protein A; D000069283:Rituximab; D003907:Dexamethasone; D001379:Azathioprine